Showing results (1661-1670 of 2,000) with videos related to
Sort By:
Pageof 200
Drug and Alcohol Dependence|April 13, 2025
Covariates in studies examining longitudinal relationships between substance use and mental health problems among youth: A meta-epidemiologic reviewJillian Halladay, Steph Kershaw, Emma K Devine, et al.Journal of Wound Care|January 24, 2008
Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcersJ R Hanft, R A Pollak, A Barbul, et al.Ecology|March 22, 2014
Modeling structured population dynamics using data from unmarked individualsElise F Zipkin, James T Thorson, Kevin See, et al.Plos Pathogens|January 8, 2025
MCP5, a methyl-accepting chemotaxis protein regulated by both the Hk1-Rrp1 and Rrp2-RpoN-RpoS pathways, is required for the immune evasion of Borrelia burgdorferiSajith Raghunandanan, Kai Zhang, Yan Zhang, et al.Scientific Data|April 23, 2020
FiCli, the Fish and Climate Change Database, informs climate adaptation and management for freshwater fishesTrevor J Krabbenhoft, Bonnie J E Myers, Jesse P Wong, et al.The Journal of Thoracic and Cardiovascular Surgery|December 31, 1997
Induction therapy for esophageal cancer with paclitaxel and hyperfractionated radiotherapy: a phase I and II studyC D Wright, J C Wain, T J Lynch, et al.The Journal of Thoracic and Cardiovascular Surgery|December 30, 2009
The successful application of simulation-based training in thoracic surgery residencyHarold M Burkhart, Jeffrey B Riley, Sarah E Hendrickson, et al.British Journal of Cancer|August 16, 2012
MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcomeJ Ryan, A Tivnan, J Fay, et al.Molecular and Cellular Biology|December 22, 2010
β-Arrestin 1 inhibits the GTPase-activating protein function of ARHGAP21, promoting activation of RhoA following angiotensin II type 1A receptor stimulationD F Anthony, Y Y Sin, S Vadrevu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 3, 2010
Phase I/II study of AT-101 with topotecan in relapsed and refractory small cell lung cancerRebecca Suk Heist, Jerry Fain, Bernard Chinnasami, et al.Pageof 200